Modulus Therapeutics, Inc. — Form D
Modulus Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-20. The offering totals $3.8M, of which $3.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-20
- Form: D
- Accession: 0001873311-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.8M
- Amount sold: $3.8M
- Minimum investment: $125K
- Investors: 9
- Date of first sale: 2021-07-02
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-406833
Issuer
- Name: Modulus Therapeutics, Inc.
- CIK: 0001873311
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2101 N. 34TH ST., SEATTLE, WA, 98103
- Phone: 801-534-7260
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Bryce R Daines | Director | Seattle, WA |
| Max C Darnell | Director | Seattle, WA |
| Bryce R Daines | Executive Officer | Seattle, WA |
| Max C Darnell | Executive Officer | Seattle, WA |
More